| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlorides | 24 | 2024 | 667 | 6.150 |
Why?
|
| Epilepsy | 46 | 2023 | 3310 | 4.290 |
Why?
|
| Hippocampus | 56 | 2022 | 3675 | 3.490 |
Why?
|
| Seizures | 26 | 2022 | 2859 | 2.850 |
Why?
|
| Bumetanide | 11 | 2022 | 95 | 2.740 |
Why?
|
| Neurons | 49 | 2023 | 9338 | 2.710 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 11 | 2022 | 135 | 2.360 |
Why?
|
| Action Potentials | 28 | 2019 | 1806 | 2.200 |
Why?
|
| gamma-Aminobutyric Acid | 17 | 2021 | 1121 | 2.090 |
Why?
|
| Receptors, GABA-A | 17 | 2014 | 627 | 1.920 |
Why?
|
| Symporters | 7 | 2021 | 362 | 1.830 |
Why?
|
| Nerve Net | 14 | 2018 | 2174 | 1.520 |
Why?
|
| Synapses | 22 | 2018 | 1728 | 1.380 |
Why?
|
| Chloride Channels | 7 | 2014 | 227 | 1.340 |
Why?
|
| Synaptic Transmission | 13 | 2021 | 1178 | 1.330 |
Why?
|
| Anticonvulsants | 18 | 2023 | 1916 | 1.310 |
Why?
|
| Organ Culture Techniques | 13 | 2017 | 813 | 1.210 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 9 | 2016 | 102 | 1.190 |
Why?
|
| Neocortex | 5 | 2023 | 400 | 1.180 |
Why?
|
| Brain Injuries | 8 | 2023 | 2025 | 1.110 |
Why?
|
| Phenobarbital | 6 | 2020 | 193 | 1.090 |
Why?
|
| Pyramidal Cells | 11 | 2018 | 363 | 1.040 |
Why?
|
| Neural Inhibition | 11 | 2015 | 602 | 1.030 |
Why?
|
| Rats | 63 | 2017 | 24260 | 1.010 |
Why?
|
| Electroencephalography | 22 | 2022 | 6150 | 0.990 |
Why?
|
| Miller Fisher Syndrome | 1 | 2022 | 7 | 0.860 |
Why?
|
| Kainic Acid | 11 | 2021 | 199 | 0.840 |
Why?
|
| Membrane Potentials | 18 | 2014 | 1137 | 0.830 |
Why?
|
| Dextrans | 1 | 2024 | 595 | 0.810 |
Why?
|
| Animals, Newborn | 14 | 2021 | 2726 | 0.800 |
Why?
|
| Ophthalmoplegia | 1 | 2022 | 166 | 0.770 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2022 | 120 | 0.760 |
Why?
|
| Animals | 113 | 2023 | 168757 | 0.760 |
Why?
|
| Rats, Sprague-Dawley | 27 | 2017 | 8301 | 0.710 |
Why?
|
| Disease Models, Animal | 27 | 2023 | 18029 | 0.710 |
Why?
|
| Brain | 23 | 2023 | 26385 | 0.690 |
Why?
|
| Models, Neurological | 8 | 2018 | 1774 | 0.680 |
Why?
|
| Cytoplasm | 2 | 2021 | 1539 | 0.640 |
Why?
|
| Mannitol | 1 | 2019 | 181 | 0.640 |
Why?
|
| Convulsants | 4 | 2010 | 70 | 0.630 |
Why?
|
| Thalamus | 2 | 2016 | 1023 | 0.590 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 582 | 0.570 |
Why?
|
| Cell Death | 6 | 2023 | 1706 | 0.570 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 8 | 2008 | 895 | 0.560 |
Why?
|
| Status Epilepticus | 6 | 2010 | 444 | 0.560 |
Why?
|
| Excitatory Amino Acid Antagonists | 8 | 2013 | 449 | 0.550 |
Why?
|
| Diuretics | 2 | 2011 | 592 | 0.530 |
Why?
|
| Interneurons | 6 | 2015 | 577 | 0.520 |
Why?
|
| Excitatory Postsynaptic Potentials | 8 | 2018 | 377 | 0.510 |
Why?
|
| Brain Waves | 3 | 2018 | 401 | 0.510 |
Why?
|
| Patch-Clamp Techniques | 7 | 2018 | 964 | 0.490 |
Why?
|
| Brain Edema | 2 | 2017 | 617 | 0.490 |
Why?
|
| Neuronal Plasticity | 6 | 2013 | 1422 | 0.470 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 262 | 0.450 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 2219 | 0.430 |
Why?
|
| Dentate Gyrus | 3 | 2009 | 160 | 0.420 |
Why?
|
| Water | 1 | 2019 | 1395 | 0.420 |
Why?
|
| Kynurenic Acid | 5 | 2013 | 46 | 0.420 |
Why?
|
| Biological Clocks | 2 | 2011 | 321 | 0.410 |
Why?
|
| Epilepsy, Benign Neonatal | 2 | 2008 | 16 | 0.400 |
Why?
|
| Presynaptic Terminals | 3 | 2018 | 302 | 0.380 |
Why?
|
| Dendrites | 3 | 2004 | 485 | 0.370 |
Why?
|
| Cerebral Cortex | 9 | 2015 | 5708 | 0.360 |
Why?
|
| Papilledema | 1 | 2011 | 118 | 0.350 |
Why?
|
| Pseudotumor Cerebri | 1 | 2011 | 100 | 0.350 |
Why?
|
| Mice | 25 | 2022 | 81183 | 0.340 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1741 | 0.340 |
Why?
|
| Percussion | 1 | 2008 | 18 | 0.340 |
Why?
|
| Brain Chemistry | 3 | 2018 | 981 | 0.330 |
Why?
|
| Surgical Equipment | 1 | 2008 | 57 | 0.330 |
Why?
|
| DNA, Viral | 1 | 2015 | 2225 | 0.320 |
Why?
|
| Picrotoxin | 3 | 2009 | 65 | 0.320 |
Why?
|
| Telemetry | 6 | 2010 | 205 | 0.320 |
Why?
|
| Periodicity | 2 | 2007 | 363 | 0.320 |
Why?
|
| Electrophysiology | 8 | 2010 | 1308 | 0.320 |
Why?
|
| Signal Transduction | 7 | 2016 | 23403 | 0.310 |
Why?
|
| Entorhinal Cortex | 2 | 2013 | 272 | 0.310 |
Why?
|
| Leigh Disease | 1 | 2008 | 75 | 0.310 |
Why?
|
| Evoked Potentials | 6 | 2013 | 1056 | 0.300 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2007 | 67 | 0.290 |
Why?
|
| Glutamic Acid | 4 | 2007 | 1169 | 0.280 |
Why?
|
| Cortical Synchronization | 1 | 2006 | 79 | 0.280 |
Why?
|
| Bicarbonates | 2 | 1999 | 313 | 0.280 |
Why?
|
| Acetazolamide | 3 | 2012 | 100 | 0.280 |
Why?
|
| Probability | 1 | 2011 | 2505 | 0.270 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2010 | 652 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2503 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2014 | 3748 | 0.260 |
Why?
|
| Time Factors | 17 | 2021 | 40075 | 0.260 |
Why?
|
| Estrous Cycle | 1 | 2005 | 73 | 0.260 |
Why?
|
| Potassium | 3 | 2004 | 1336 | 0.260 |
Why?
|
| GABA Antagonists | 4 | 2012 | 128 | 0.250 |
Why?
|
| Electric Stimulation | 7 | 2013 | 1767 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2109 | 0.250 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 320 | 0.250 |
Why?
|
| Neurofibromatoses | 1 | 2009 | 299 | 0.250 |
Why?
|
| Halogens | 1 | 2024 | 13 | 0.240 |
Why?
|
| Coloring Agents | 2 | 2024 | 566 | 0.240 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2008 | 403 | 0.240 |
Why?
|
| Ion Transport | 4 | 2009 | 320 | 0.240 |
Why?
|
| Cannabinoids | 1 | 2006 | 166 | 0.240 |
Why?
|
| Myotonia Congenita | 1 | 2023 | 16 | 0.230 |
Why?
|
| Nervous System Diseases | 3 | 2020 | 1622 | 0.230 |
Why?
|
| Analysis of Variance | 6 | 2014 | 6365 | 0.230 |
Why?
|
| Malignant Hyperthermia | 1 | 2023 | 73 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2938 | 0.230 |
Why?
|
| Neural Pathways | 3 | 2011 | 2972 | 0.220 |
Why?
|
| Rats, Wistar | 8 | 2004 | 1901 | 0.220 |
Why?
|
| Headache | 1 | 2011 | 1226 | 0.220 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2014 | 3772 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2014 | 10943 | 0.210 |
Why?
|
| Mice, Transgenic | 7 | 2014 | 9734 | 0.210 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 647 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 21827 | 0.210 |
Why?
|
| Fragile X Syndrome | 1 | 2023 | 115 | 0.210 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2008 | 770 | 0.210 |
Why?
|
| Phenytoin | 2 | 2013 | 197 | 0.210 |
Why?
|
| Piperidines | 1 | 2010 | 1602 | 0.200 |
Why?
|
| Calcium | 5 | 2022 | 5756 | 0.200 |
Why?
|
| Amygdala | 1 | 2009 | 1315 | 0.200 |
Why?
|
| Protein Subunits | 1 | 2005 | 959 | 0.200 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 884 | 0.200 |
Why?
|
| Potassium Channels | 1 | 2004 | 563 | 0.200 |
Why?
|
| Drugs, Investigational | 2 | 2013 | 214 | 0.200 |
Why?
|
| Equipment Design | 2 | 2010 | 3582 | 0.200 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2005 | 712 | 0.190 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 506 | 0.190 |
Why?
|
| Luminescent Proteins | 2 | 2015 | 853 | 0.190 |
Why?
|
| Humans | 57 | 2023 | 744343 | 0.190 |
Why?
|
| Cytosol | 1 | 2024 | 901 | 0.190 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2022 | 311 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2013 | 1375 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2010 | 2925 | 0.180 |
Why?
|
| Ataxia | 1 | 2022 | 304 | 0.180 |
Why?
|
| Pyrazoles | 1 | 2010 | 1972 | 0.180 |
Why?
|
| Male | 41 | 2021 | 350118 | 0.180 |
Why?
|
| Sodium Chloride Symporters | 1 | 2019 | 11 | 0.170 |
Why?
|
| Stroke | 5 | 2021 | 9981 | 0.170 |
Why?
|
| Propionates | 3 | 2009 | 169 | 0.170 |
Why?
|
| 2-Amino-5-phosphonovalerate | 3 | 2007 | 62 | 0.170 |
Why?
|
| Diuretics, Osmotic | 1 | 2019 | 37 | 0.170 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2009 | 146 | 0.170 |
Why?
|
| Computer Simulation | 5 | 2018 | 6196 | 0.160 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2018 | 33 | 0.160 |
Why?
|
| Epilepsy, Rolandic | 1 | 2019 | 50 | 0.160 |
Why?
|
| Antiporters | 1 | 1999 | 277 | 0.160 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2022 | 584 | 0.160 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.160 |
Why?
|
| Advisory Committees | 2 | 2023 | 775 | 0.150 |
Why?
|
| Algorithms | 6 | 2018 | 13881 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2023 | 560 | 0.150 |
Why?
|
| Disease Progression | 4 | 2018 | 13284 | 0.150 |
Why?
|
| Phagocytosis | 1 | 2023 | 1539 | 0.150 |
Why?
|
| Gold | 2 | 2012 | 484 | 0.150 |
Why?
|
| Adenoviridae | 2 | 2000 | 1099 | 0.140 |
Why?
|
| Scalp | 1 | 2019 | 380 | 0.140 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2012 | 58 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 4 | 2013 | 4462 | 0.130 |
Why?
|
| Neurosciences | 1 | 2020 | 348 | 0.130 |
Why?
|
| Feedback, Psychological | 1 | 2015 | 97 | 0.130 |
Why?
|
| Infant, Newborn | 6 | 2022 | 25625 | 0.130 |
Why?
|
| Recurrence | 4 | 2010 | 8340 | 0.130 |
Why?
|
| Microglia | 1 | 2023 | 1266 | 0.130 |
Why?
|
| Indoles | 1 | 2023 | 1839 | 0.130 |
Why?
|
| Culture Media | 1 | 2017 | 908 | 0.130 |
Why?
|
| Biological Transport | 2 | 2014 | 2118 | 0.120 |
Why?
|
| Cell Membrane Permeability | 2 | 2014 | 590 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase (Cytochrome) | 1 | 2013 | 1 | 0.120 |
Why?
|
| Electrodes | 3 | 2010 | 619 | 0.120 |
Why?
|
| Microelectrodes | 3 | 2008 | 303 | 0.120 |
Why?
|
| Biphenyl Compounds | 2 | 2008 | 913 | 0.110 |
Why?
|
| Receptors, AMPA | 2 | 2006 | 331 | 0.110 |
Why?
|
| Glutamate Decarboxylase | 2 | 2012 | 245 | 0.110 |
Why?
|
| Riluzole | 1 | 2013 | 55 | 0.110 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2013 | 56 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2015 | 1950 | 0.110 |
Why?
|
| GABA-A Receptor Antagonists | 3 | 2003 | 62 | 0.110 |
Why?
|
| Adenosine | 2 | 2009 | 825 | 0.110 |
Why?
|
| Phosphinic Acids | 1 | 2012 | 19 | 0.110 |
Why?
|
| Thioglycolates | 1 | 2012 | 39 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 2 | 2010 | 1005 | 0.110 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2020 | 333 | 0.110 |
Why?
|
| Barbiturates | 1 | 1992 | 114 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 7913 | 0.100 |
Why?
|
| Electric Conductivity | 4 | 1998 | 411 | 0.100 |
Why?
|
| Neurology | 1 | 2020 | 763 | 0.100 |
Why?
|
| Lactic Acid | 2 | 2017 | 1133 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2011 | 32 | 0.100 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2011 | 21 | 0.100 |
Why?
|
| Propanolamines | 1 | 2012 | 167 | 0.100 |
Why?
|
| Axons | 2 | 2013 | 1684 | 0.100 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2010 | 30 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2012 | 91 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3420 | 0.100 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2013 | 629 | 0.090 |
Why?
|
| Ambulances | 1 | 2011 | 95 | 0.090 |
Why?
|
| Extracellular Fluid | 2 | 2009 | 167 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 135 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2014 | 645 | 0.090 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 203 | 0.090 |
Why?
|
| Choline | 1 | 2012 | 493 | 0.090 |
Why?
|
| Valine | 1 | 2012 | 413 | 0.090 |
Why?
|
| Female | 18 | 2020 | 380194 | 0.090 |
Why?
|
| Anti-Anxiety Agents | 1 | 1992 | 390 | 0.090 |
Why?
|
| Lidocaine | 1 | 2013 | 544 | 0.090 |
Why?
|
| Fetal Monitoring | 1 | 1990 | 70 | 0.090 |
Why?
|
| Emergency Medical Services | 3 | 2011 | 1917 | 0.090 |
Why?
|
| Granulocytes | 1 | 1991 | 548 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 941 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15076 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 849 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6171 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 2647 | 0.090 |
Why?
|
| Cells, Cultured | 8 | 2023 | 19229 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 2 | 2020 | 855 | 0.080 |
Why?
|
| Apoptosis | 2 | 2023 | 9727 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 497 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1119 | 0.080 |
Why?
|
| Rotation | 1 | 2010 | 523 | 0.080 |
Why?
|
| Lethargy | 1 | 2008 | 39 | 0.080 |
Why?
|
| Caspases | 1 | 2012 | 928 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2373 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2025 | 0.080 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2008 | 59 | 0.080 |
Why?
|
| Video Recording | 2 | 2013 | 949 | 0.080 |
Why?
|
| Gene Expression | 3 | 1997 | 7799 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 1423 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 2015 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1677 | 0.080 |
Why?
|
| Pain | 1 | 2003 | 4986 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11366 | 0.080 |
Why?
|
| Age Factors | 4 | 2021 | 18370 | 0.080 |
Why?
|
| Nerve Fibers | 1 | 1991 | 687 | 0.080 |
Why?
|
| Magnesium Deficiency | 1 | 2008 | 47 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1086 | 0.080 |
Why?
|
| Cell Count | 1 | 2012 | 1856 | 0.080 |
Why?
|
| Quinoxalines | 2 | 2004 | 290 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2015 | 1900 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1663 | 0.080 |
Why?
|
| Strontium | 1 | 2007 | 20 | 0.080 |
Why?
|
| Neurofibromin 1 | 1 | 2009 | 196 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2429 | 0.070 |
Why?
|
| Monitoring, Physiologic | 3 | 2010 | 1738 | 0.070 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2008 | 184 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 1991 | 748 | 0.070 |
Why?
|
| Receptors, Cannabinoid | 1 | 2006 | 44 | 0.070 |
Why?
|
| Hypothermia | 1 | 2008 | 189 | 0.070 |
Why?
|
| Metabolomics | 1 | 2015 | 1484 | 0.070 |
Why?
|
| Swine | 3 | 2023 | 5917 | 0.070 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1990 | 525 | 0.070 |
Why?
|
| Dura Mater | 1 | 2008 | 291 | 0.070 |
Why?
|
| Feedback | 2 | 2001 | 795 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 596 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2012 | 2557 | 0.070 |
Why?
|
| Models, Biological | 3 | 2008 | 9583 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2886 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 625 | 0.070 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2010 | 339 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1970 | 0.070 |
Why?
|
| Aging | 2 | 2003 | 8664 | 0.070 |
Why?
|
| Long-Term Potentiation | 1 | 2007 | 293 | 0.070 |
Why?
|
| Artifacts | 2 | 2023 | 1904 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2263 | 0.070 |
Why?
|
| Sirolimus | 1 | 2013 | 1564 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2009 | 9146 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2010 | 1011 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 405 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 534 | 0.070 |
Why?
|
| Neurophysiology | 1 | 2006 | 142 | 0.060 |
Why?
|
| Pressure | 1 | 2008 | 1203 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2009 | 1534 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2005 | 387 | 0.060 |
Why?
|
| Pilocarpine | 1 | 2004 | 63 | 0.060 |
Why?
|
| Thiazoles | 1 | 2012 | 1483 | 0.060 |
Why?
|
| Mutation | 3 | 2016 | 29786 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6489 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 6473 | 0.060 |
Why?
|
| Astrocytes | 1 | 2012 | 1270 | 0.060 |
Why?
|
| Craniotomy | 1 | 2008 | 729 | 0.060 |
Why?
|
| Culture Techniques | 3 | 1994 | 554 | 0.060 |
Why?
|
| tau Proteins | 1 | 2013 | 1868 | 0.060 |
Why?
|
| Ion Channels | 3 | 1994 | 1056 | 0.060 |
Why?
|
| Livestock | 1 | 2023 | 19 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2008 | 1792 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1850 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1071 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2019 | 41006 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 1736 | 0.060 |
Why?
|
| Software | 1 | 2017 | 4443 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1587 | 0.060 |
Why?
|
| Microfluidics | 1 | 2008 | 662 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15540 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 828 | 0.060 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2003 | 84 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2003 | 111 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 817 | 0.050 |
Why?
|
| Pentobarbital | 1 | 2003 | 155 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 2186 | 0.050 |
Why?
|
| Fetus | 1 | 1990 | 1880 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3798 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 1364 | 0.050 |
Why?
|
| Phantom Limb | 1 | 2003 | 91 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 719 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 479 | 0.050 |
Why?
|
| Wakefulness | 1 | 2008 | 1245 | 0.050 |
Why?
|
| Protein Transport | 1 | 2007 | 1988 | 0.050 |
Why?
|
| Adolescent | 6 | 2019 | 85781 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1184 | 0.050 |
Why?
|
| Spinal Cord | 2 | 2003 | 1809 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2021 | 1121 | 0.050 |
Why?
|
| Off-Road Motor Vehicles | 1 | 2001 | 17 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2005 | 1150 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 3617 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 3768 | 0.050 |
Why?
|
| GABA Modulators | 1 | 2020 | 107 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2013 | 63114 | 0.050 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 78 | 0.050 |
Why?
|
| North Carolina | 2 | 2011 | 315 | 0.050 |
Why?
|
| Porosity | 2 | 2012 | 362 | 0.050 |
Why?
|
| Accidents | 1 | 2001 | 164 | 0.050 |
Why?
|
| Glycine | 1 | 2003 | 671 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2000 | 145 | 0.050 |
Why?
|
| Drug Resistance | 3 | 2013 | 1609 | 0.040 |
Why?
|
| Research Design | 2 | 2013 | 5987 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1999 | 103 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2023 | 1590 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5720 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 2025 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2008 | 1563 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2009 | 2585 | 0.040 |
Why?
|
| Fluoresceins | 2 | 2009 | 235 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2005 | 5102 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 247 | 0.040 |
Why?
|
| Causality | 1 | 2005 | 1275 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4042 | 0.040 |
Why?
|
| DNA Repair | 1 | 2008 | 2046 | 0.040 |
Why?
|
| Receptor, Adenosine A1 | 2 | 2009 | 44 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 2214 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2009 | 14557 | 0.040 |
Why?
|
| Memory | 1 | 2006 | 2174 | 0.040 |
Why?
|
| Ganglia, Spinal | 2 | 1996 | 519 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3086 | 0.040 |
Why?
|
| Infant | 3 | 2009 | 35136 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 424 | 0.030 |
Why?
|
| Adult | 6 | 2023 | 214055 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.030 |
Why?
|
| Muscimol | 1 | 1995 | 69 | 0.030 |
Why?
|
| Sodium | 1 | 2001 | 1623 | 0.030 |
Why?
|
| Amiloride | 1 | 1995 | 121 | 0.030 |
Why?
|
| Bicuculline | 2 | 1992 | 99 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 8037 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2022 | 13033 | 0.030 |
Why?
|
| Prosencephalon | 1 | 1997 | 303 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 5867 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2009 | 3265 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 427 | 0.030 |
Why?
|
| Receptors, Glycine | 1 | 1994 | 32 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
| Language | 1 | 2023 | 1471 | 0.030 |
Why?
|
| Septum Pellucidum | 1 | 1994 | 58 | 0.030 |
Why?
|
| Learning | 1 | 2023 | 1713 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2005 | 2690 | 0.030 |
Why?
|
| Tetrodotoxin | 2 | 1991 | 259 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 206 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6442 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1994 | 141 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12959 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2009 | 1460 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 213383 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10388 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 56430 | 0.030 |
Why?
|
| GABA Agents | 1 | 2012 | 42 | 0.030 |
Why?
|
| Scrapie | 1 | 1991 | 22 | 0.030 |
Why?
|
| Kindling, Neurologic | 1 | 1992 | 30 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 12072 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 1991 | 17 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1997 | 4554 | 0.030 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 1991 | 10 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1992 | 178 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2012 | 81 | 0.030 |
Why?
|
| Magnesium | 1 | 1995 | 813 | 0.030 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2013 | 323 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2012 | 171 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 315 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 7659 | 0.030 |
Why?
|
| Genes, Synthetic | 1 | 1991 | 90 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 1992 | 232 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 35421 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 197 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1992 | 440 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 574 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2892 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 2008 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 392 | 0.020 |
Why?
|
| Diffusion | 1 | 2012 | 833 | 0.020 |
Why?
|
| Prions | 1 | 1991 | 180 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1992 | 398 | 0.020 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2009 | 27 | 0.020 |
Why?
|
| Logistic Models | 2 | 2018 | 13408 | 0.020 |
Why?
|
| Xanthines | 1 | 2009 | 121 | 0.020 |
Why?
|
| Silver | 1 | 2010 | 122 | 0.020 |
Why?
|
| Time | 1 | 2011 | 542 | 0.020 |
Why?
|
| Child | 4 | 2023 | 77709 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2013 | 705 | 0.020 |
Why?
|
| Behavior, Animal | 2 | 2008 | 1881 | 0.020 |
Why?
|
| Aconitum | 1 | 2008 | 1 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 2400 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1992 | 622 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 964 | 0.020 |
Why?
|
| Cost Savings | 1 | 2013 | 926 | 0.020 |
Why?
|
| Fumarate Hydratase | 1 | 2008 | 47 | 0.020 |
Why?
|
| Cricetinae | 1 | 1991 | 2472 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 1364 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5021 | 0.020 |
Why?
|
| Cell Communication | 1 | 1995 | 1621 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 2008 | 84 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
| Homeostasis | 2 | 1998 | 3340 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 2478 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 868 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2008 | 337 | 0.020 |
Why?
|
| Base Sequence | 2 | 1996 | 12797 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 128 | 0.020 |
Why?
|
| Amyloid | 1 | 1991 | 795 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 778 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12026 | 0.020 |
Why?
|
| Neurites | 1 | 2008 | 388 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1992 | 1101 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.020 |
Why?
|
| Electronics, Medical | 1 | 2006 | 71 | 0.020 |
Why?
|
| Hypocapnia | 1 | 2005 | 34 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 729 | 0.020 |
Why?
|
| Cell Separation | 1 | 1992 | 1751 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 18111 | 0.020 |
Why?
|
| Acids | 1 | 2005 | 127 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2007 | 352 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2971 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 153 | 0.020 |
Why?
|
| Leucine | 1 | 2006 | 561 | 0.020 |
Why?
|
| Brain Stem | 1 | 1990 | 846 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2005 | 260 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 731 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1572 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1504 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
| Reaction Time | 1 | 1990 | 2097 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 1017 | 0.010 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 980 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2006 | 957 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2006 | 1266 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1461 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 839 | 0.010 |
Why?
|
| Arkansas | 1 | 2001 | 52 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2000 | 84 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 76 | 0.010 |
Why?
|
| Oocytes | 1 | 2006 | 1187 | 0.010 |
Why?
|
| Risk Factors | 3 | 2019 | 72290 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2018 | 77449 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5952 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 19905 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2010 | 3313 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15997 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14722 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 1998 | 200 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 1177 | 0.010 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 1996 | 13 | 0.010 |
Why?
|
| Deoxycytosine Nucleotides | 1 | 1996 | 14 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2006 | 1210 | 0.010 |
Why?
|
| Digoxigenin | 1 | 1996 | 26 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 732 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1992 | 6669 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1998 | 546 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 462 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 438 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 5137 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 5391 | 0.010 |
Why?
|
| Nucleosomes | 1 | 1996 | 494 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 163280 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1994 | 219 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1996 | 1267 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1996 | 1060 | 0.010 |
Why?
|
| Cerebellum | 1 | 1998 | 1488 | 0.010 |
Why?
|
| Mitosis | 1 | 1996 | 1208 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1996 | 1951 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8949 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 4568 | 0.000 |
Why?
|
| Pregnancy | 1 | 1990 | 29144 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6386 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 57776 | 0.000 |
Why?
|
| Cell Survival | 1 | 1994 | 5882 | 0.000 |
Why?
|
| DNA | 1 | 1996 | 7301 | 0.000 |
Why?
|